$EXPO
EXPONENT INC

2021 Q1 Form 10-K Financial Statement

#000156459021009433 Filed on February 26, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2021 2020 Q4
Revenue $103.2M $399.9M $98.66M
YoY Change -6.28% -4.15%
Cost Of Revenue $5.900M $31.42M $5.200M
YoY Change -25.32% 46.13%
Gross Profit $97.30M $434.9M $93.50M
YoY Change -4.79% 14.92%
Gross Profit Margin 94.28% 108.74% 94.77%
Selling, General & Admin $71.10M $293.3M $67.40M
YoY Change -3.79% 11.57%
% of Gross Profit 73.07% 67.46% 72.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.700M $6.487M $1.700M
YoY Change -10.53% -5.99%
% of Gross Profit 1.75% 1.49% 1.82%
Operating Expenses $79.60M $316.7M $73.10M
YoY Change -1.61% -4.65%
Operating Profit $17.70M $83.25M $20.41M
YoY Change -17.1% -2.19%
Interest Expense $200.0K $14.28M $300.0K
YoY Change -80.0% 38.63%
% of Operating Profit 1.13% 17.15% 1.47%
Other Income/Expense, Net $8.900M $11.98M $3.915M
YoY Change 102.27% -21.0%
Pretax Income $26.83M $96.94M $24.64M
YoY Change 0.09% -6.96%
Income Tax $5.000M $14.38M $6.600M
% Of Pretax Income 18.64% 14.84% 26.79%
Net Earnings $21.84M $101.2M $18.08M
YoY Change 14.22% 22.73%
Net Earnings / Revenue 21.16% 25.31% 18.33%
Basic Earnings Per Share $0.42 $1.58 $0.35
Diluted Earnings Per Share $0.41 $1.55 $0.34
COMMON SHARES
Basic Shares Outstanding 52.40M 52.39M 52.32M
Diluted Shares Outstanding 53.26M 53.32M 53.21M

Balance Sheet

Concept 2021 Q1 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $242.5M $297.7M $207.7M
YoY Change 4.71% 22.76%
Cash & Equivalents $197.5M $101.6M $76.30M
Short-Term Investments $45.00M $20.10M
Other Short-Term Assets $12.70M $15.21M $11.00M
YoY Change 3.25% 19.8%
Inventory
Prepaid Expenses
Receivables $111.6M $139.9M $110.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $366.8M $452.8M $328.6M
YoY Change 0.77% 23.44%
LONG-TERM ASSETS
Property, Plant & Equipment $59.82M $74.34M $80.50M
YoY Change -2.86% -6.02%
Goodwill $8.607M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.242M $148.0M $116.9M
YoY Change 30.87% 17.95%
Total Long-Term Assets $213.3M $231.0M $206.1M
YoY Change 6.97% 8.29%
TOTAL ASSETS
Total Short-Term Assets $366.8M $452.8M $328.6M
Total Long-Term Assets $213.3M $231.0M $206.1M
Total Assets $580.1M $683.7M $534.7M
YoY Change 2.96% 17.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.279M $3.193M $18.60M
YoY Change -29.39% -3.24%
Accrued Expenses $13.05M $130.0M $68.40M
YoY Change -6.39% 27.23%
Deferred Revenue $11.80M
YoY Change -7.16%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $117.3M $153.0M $96.40M
YoY Change -5.37% 30.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.986M $113.7M $95.10M
YoY Change 11.88% 12.23%
Total Long-Term Liabilities $2.986M $113.7M $95.10M
YoY Change 11.88% 12.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $117.3M $153.0M $96.40M
Total Long-Term Liabilities $2.986M $113.7M $95.10M
Total Liabilities $218.6M $266.7M $191.5M
YoY Change 2.55% 21.99%
SHAREHOLDERS EQUITY
Retained Earnings $421.8M
YoY Change 9.66%
Common Stock $265.4M
YoY Change 8.32%
Preferred Stock
YoY Change
Treasury Stock (at cost) $323.8M
YoY Change 16.61%
Treasury Stock Shares $13.90M
Shareholders Equity $361.5M $417.1M $343.2M
YoY Change
Total Liabilities & Shareholders Equity $580.1M $683.7M $534.7M
YoY Change 2.96% 17.87%

Cashflow Statement

Concept 2021 Q1 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $21.84M $101.2M $18.08M
YoY Change 14.22% 22.73%
Depreciation, Depletion And Amortization $1.700M $6.487M $1.700M
YoY Change -10.53% -5.99%
Cash From Operating Activities $40.90M $103.3M $28.20M
YoY Change -26.7% -4.39%
INVESTING ACTIVITIES
Capital Expenditures -$900.0K $4.987M -$1.600M
YoY Change -85.0% -78.35%
Acquisitions
YoY Change
Other Investing Activities -$25.00M $45.00M $14.00M
YoY Change -213.64% 350.04%
Cash From Investing Activities -$25.90M $5.024M $12.40M
YoY Change -261.88% 17.69%
FINANCING ACTIVITIES
Cash Dividend Paid $43.20M
YoY Change 28.94%
Common Stock Issuance & Retirement, Net $40.05M
YoY Change 82.4%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.200M -88.36M -9.300M
YoY Change -78.62% 39.33%
NET CHANGE
Cash From Operating Activities 40.90M 103.3M 28.20M
Cash From Investing Activities -25.90M 5.024M 12.40M
Cash From Financing Activities -6.200M -88.36M -9.300M
Net Change In Cash 8.800M 21.09M 31.30M
YoY Change -79.44% -57.29%
FREE CASH FLOW
Cash From Operating Activities $40.90M $103.3M $28.20M
Capital Expenditures -$900.0K $4.987M -$1.600M
Free Cash Flow $41.80M $98.33M $29.80M
YoY Change -32.36% 15.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M21D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M20D
CY2021 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2020Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
76357000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
145000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25820000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11183000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
40049000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2062000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1760000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
384668000
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
13951000
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
277658000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
350251000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
563411000
CY2018 expo Revenue From Reimbursement
RevenueFromReimbursement
24884000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
379523000
CY2018 us-gaap Labor And Related Expense
LaborAndRelatedExpense
215052000
CY2018 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
30599000
CY2018 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
24884000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17532000
CY2018 us-gaap Operating Expenses
OperatingExpenses
288067000
CY2018 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
354639000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
91456000
CY2018 us-gaap Investment Income Net
InvestmentIncomeNet
2751000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-890000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
93317000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21063000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
72254000
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.37
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52906000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54168000
CY2018 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.52
CY2018 us-gaap Net Income Loss
NetIncomeLoss
72254000
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
18583000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
83194000
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
86723000
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
11800000
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
12710000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5987000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5944000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
117308000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
123960000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2986000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2669000
CY2021Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
83961000
CY2020Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
68373000
CY2018 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1015000
CY2021 expo Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment On Planned Disposal Of Subsidiary Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentOnPlannedDisposalOfSubsidiaryTax
0
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-601000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
63000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
191000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
71430000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
176436000
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
55165000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3995000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4295000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
120138000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12305000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
364044000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61587000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19322000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23003000
CY2021Q1 us-gaap Goodwill
Goodwill
8607000
CY2020Q1 us-gaap Goodwill
Goodwill
8607000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
40539000
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
36821000
CY2021Q1 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
83731000
CY2020Q1 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
68400000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1242000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
949000
CY2021Q1 us-gaap Assets
Assets
580096000
CY2020Q1 us-gaap Assets
Assets
563411000
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16327000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14343000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18158000
CY2021Q1 us-gaap Liabilities
Liabilities
218598000
CY2020Q1 us-gaap Liabilities
Liabilities
213160000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
66000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
66000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
265328000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
244935000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
65000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
302000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1997000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1932000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
421809000
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
13903000
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
323773000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
361498000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
580096000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
289088000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1474000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8550000
CY2018 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
27915000
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
21957000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-601000
CY2020 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
7947000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-11183000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
347000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4940000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9165000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
40049000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
65000
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
8645000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15263000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-237000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52691000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53323000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53884000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54168000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35604
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8815000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5754000
CY2018 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6067000
CY2021 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
9408000
CY2020 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
14409000
CY2018 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
23174000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
242518000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
8000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
242526000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
231277000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
324000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
231601000
CY2021 us-gaap Dividends
Dividends
40362000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
82552000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
361498000
CY2021 us-gaap Profit Loss
ProfitLoss
82552000
CY2020 us-gaap Profit Loss
ProfitLoss
82460000
CY2018 us-gaap Profit Loss
ProfitLoss
72254000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6871000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6806000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6292000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
163000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
516000
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
114000
CY2018 expo Deferred Rent
DeferredRent
-175000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1849000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2224000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1848000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
17278000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
17466000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
16993000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3639000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2845000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3715000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6724000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16548000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2438000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9075000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3343000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11047000
CY2021 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
91000
CY2020 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
-205000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2646000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6715000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4620000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4562000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
11891000
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
9820000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-910000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3544000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
864000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
103312000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
108059000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
91188000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4987000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23038000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16298000
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
39989000
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
38693000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
50000000
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
27915000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3229000
CY2018 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1474000
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
39775000
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
33503000
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
27220000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-88355000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-63414000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-62500000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1108000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
463000
CY2018 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-603000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21089000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
49377000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2265000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Estimates are used for, but not limited to, revenue recognition, allowance for contract losses and doubtful accounts, stock-based compensation, income taxes, goodwill, the useful life of property, equipment and leasehold improvements, and operating lease liabilities. Actual results could differ from those estimates.</p>
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52388000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52906000
CY2021Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
185190000
CY2021Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
88977000
CY2021Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
88977000
CY2020Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
76357000
CY2021Q1 us-gaap Land
Land
18339000
CY2020Q1 us-gaap Land
Land
18339000
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
172310000
CY2020Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
76357000
CY2021Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
62324000
CY2020Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
60437000
CY2021Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
650000
CY2020Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1133000
CY2021Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
48728000
CY2020Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
47628000
CY2021Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
10500000
CY2020Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
10504000
CY2021Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
13201000
CY2020Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
13653000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
153742000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
151694000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
93919000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
90107000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59823000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61587000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6871000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6806000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6292000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3995000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4295000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
111565000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
120138000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3279000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4644000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13048000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13939000
CY2020Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9913000
CY2020Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.190
CY2020Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9801000
CY2020Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.190
CY2020Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9808000
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.190
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9839000
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
39361000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8240000
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
18583000
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16327000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
83194000
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
86723000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
10092000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
8017000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
8005000
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
51126000
CY2020Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
54471000
CY2021Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
9127000
CY2020Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
8878000
CY2021Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
13174000
CY2020Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
10896000
CY2021Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
5016000
CY2020Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
7984000
CY2021Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
4751000
CY2020Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
4494000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
11553000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
16498000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
16487000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1873000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1523000
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1624000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4597000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
6554000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
6667000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
18023000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
24575000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
24778000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2766000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1727000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2604000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-873000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1118000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1111000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3639000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2845000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3715000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14384000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21730000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21063000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
20357000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
21880000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
19597000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2942000
CY2021 expo Income Tax Rate Reconciliation Divestiture Of Foreign Subsidiary
IncomeTaxRateReconciliationDivestitureOfForeignSubsidiary
46000
CY2021 expo Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation
IncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensation
907000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
118000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.23
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-14000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1748000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
515000
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
340000
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1923000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.148
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
16841000
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
31619000
CY2021Q1 expo Deferred Tax Assets Operating Leases
DeferredTaxAssetsOperatingLeases
5758000
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
54218000
CY2020Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
50988000
CY2021 expo Income Tax Reconciliation Excess Tax Benefit From Share Based Compensation
IncomeTaxReconciliationExcessTaxBenefitFromShareBasedCompensation
9725000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-486000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
239000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14384000
CY2021Q1 expo Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
1969000
CY2020Q1 expo Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
1624000
CY2021Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
2091000
CY2020Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
2104000
CY2021Q1 expo Deferred Tax Liabilities Operating Leases
DeferredTaxLiabilitiesOperatingLeases
5758000
CY2020Q1 expo Deferred Tax Liabilities Operating Leases
DeferredTaxLiabilitiesOperatingLeases
6867000
CY2021Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
81000
CY2020Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
84000
CY2021Q1 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
3545000
CY2020Q1 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
2339000
CY2021Q1 expo Deferred Tax Liabilities Divestiture Of Foreign Subsidiary
DeferredTaxLiabilitiesDivestitureOfForeignSubsidiary
0
CY2020Q1 expo Deferred Tax Liabilities Divestiture Of Foreign Subsidiary
DeferredTaxLiabilitiesDivestitureOfForeignSubsidiary
956000
CY2021Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
235000
CY2020Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
193000
CY2021Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
13679000
CY2020Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
14167000
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
40539000
CY2020Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
36821000
CY2021 expo Total Excess Tax Benefit From Share Based Compensation
TotalExcessTaxBenefitFromShareBasedCompensation
12258000
CY2020 expo Total Excess Tax Benefit From Share Based Compensation
TotalExcessTaxBenefitFromShareBasedCompensation
8067000
CY2018 expo Total Excess Tax Benefit From Share Based Compensation
TotalExcessTaxBenefitFromShareBasedCompensation
4154000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
7522000
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
2823000
CY2020 expo Gain Loss On Deferred Compensation Investments
GainLossOnDeferredCompensationInvestments
12834000
CY2018 expo Gain Loss On Deferred Compensation Investments
GainLossOnDeferredCompensationInvestments
-3900000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-840000
CY2018 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
167000
CY2020 expo Other Miscellaneous Income Loss Net
OtherMiscellaneousIncomeLossNet
32000
CY2018 expo Other Miscellaneous Income Loss Net
OtherMiscellaneousIncomeLossNet
20000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15167000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-890000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
275000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
325000
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1873000
CY2021Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1514000
CY2021 expo Unrecognized Liability For Uncertain Tax Positions For Next Twelve Months
UnrecognizedLiabilityForUncertainTaxPositionsForNextTwelveMonths
0
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.190
CY2019Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.160
CY2019Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.160
CY2019Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8306000
CY2019Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.160
CY2019Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8323000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.160
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8280000
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
33149000
CY2021 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
4538000
CY2020 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5146000
CY2018 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5892000
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
636000
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
40049000
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
342000
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
21957000
CY2018 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
562000
CY2018 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
27915000
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
45000000
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000
CY2021Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
75455000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
31300000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
25600000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
23200000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
68.21
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
57.08
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
40.61
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
662149
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
40000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
79.43
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
283755
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
17.41
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
418394
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.29
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
21364000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
28636000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-237000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
347000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
191000
CY2021 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
8645000
CY2020 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
7947000
CY2018 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
7643000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
602000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1231000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2436000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
29480000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417199000
CY2020 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
22290000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6806000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61587000
CY2020 us-gaap Revenues
Revenues
417199000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
263894
CY2020 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
22066000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
18211000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
29.24
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
16042000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9651000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
19.73
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.16
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.59
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
17278000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
17466000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
16993000
CY2021 expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
12258000
CY2020 expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
8067000
CY2018 expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
4467000
CY2021 expo Defined Contribution Plan Employer Contribution Percentage Of Eligible Wages
DefinedContributionPlanEmployerContributionPercentageOfEligibleWages
0.07
CY2021 expo Defined Contribution Plan Employer Contribution Percentage Of Eligible Wages
DefinedContributionPlanEmployerContributionPercentageOfEligibleWages
0.07
CY2021 expo Defined Contribution Plan Employer Contribution Percentage Of Eligible Wages
DefinedContributionPlanEmployerContributionPercentageOfEligibleWages
0.07
CY2021 expo Defined Contribution Plan Employer Contribution Annual Vesting Percentage
DefinedContributionPlanEmployerContributionAnnualVestingPercentage
0.20
CY2021 expo Defined Contribution Plan Employer Contribution Annual Vesting Period
DefinedContributionPlanEmployerContributionAnnualVestingPeriod
P5Y
CY2021 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
9752000
CY2020 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
9073000
CY2018 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
8419000
CY2021Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
88747000
CY2020Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
75934000
CY2021Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
88977000
CY2021 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
8028000
CY2020 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
12834000
CY2018 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-3900000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
6968000
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6555000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5340000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3672000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2252000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1491000
CY2021Q1 expo Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
1507000
CY2021Q1 expo Lessee Operating Lease Liability Payments Due Year Seven
LesseeOperatingLeaseLiabilityPaymentsDueYearSeven
1466000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
22283000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1953000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
20330000
CY2021 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
3351000
CY2020 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
3141000
CY2021 expo Gain Loss On Deferred Compensation Investments
GainLossOnDeferredCompensationInvestments
8028000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
592000
CY2021 expo Other Miscellaneous Income Loss Net
OtherMiscellaneousIncomeLossNet
11000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11982000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
20118000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
482000
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
399900000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
83249000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
85111000
CY2021 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
5107000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6871000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59823000
CY2021 us-gaap Revenues
Revenues
399900000
CY2020Q1 us-gaap Goodwill
Goodwill
8607000
CY2021Q1 us-gaap Goodwill
Goodwill
8607000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2020Q2 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
99720000
CY2020Q3 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
87863000
CY2020Q2 us-gaap Revenues
Revenues
105953000
CY2020Q3 us-gaap Revenues
Revenues
92045000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
35988000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9120000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
24055000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
21414000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
26282000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
16346000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52575000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52259000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53657000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53139000
CY2019Q1 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
93401000
CY2019Q2 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
100263000
CY2019Q1 us-gaap Revenues
Revenues
99031000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
26829000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
24638000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
18084000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
21840000
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52316000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52402000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53209000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53260000
CY2019Q3 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
95506000
expo Revenue Before Reimbursements
RevenueBeforeReimbursements
102220000
CY2019Q3 us-gaap Revenues
Revenues
101548000
us-gaap Revenues
Revenues
110114000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23184000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
15754000
us-gaap Operating Income Loss
OperatingIncomeLoss
21350000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
25211000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
26806000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
19633000
us-gaap Net Income Loss
NetIncomeLoss
19121000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52802000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52681000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54002000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53817000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
24823000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
23322000
CY2019Q2 us-gaap Revenues
Revenues
106506000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
28851000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
22712000
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
20994000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53814000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53872000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52536000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52745000

Files In Submission

Name View Source Status
0001564590-21-009433-index-headers.html Edgar Link pending
0001564590-21-009433-index.html Edgar Link pending
0001564590-21-009433.txt Edgar Link pending
0001564590-21-009433-xbrl.zip Edgar Link pending
expo-10k_20210101.htm Edgar Link pending
expo-10k_20210101_htm.xml Edgar Link completed
expo-20210101.xsd Edgar Link pending
expo-20210101_cal.xml Edgar Link unprocessable
expo-20210101_def.xml Edgar Link unprocessable
expo-20210101_lab.xml Edgar Link unprocessable
expo-20210101_pre.xml Edgar Link unprocessable
expo-ex1038_9.htm Edgar Link pending
expo-ex1039_12.htm Edgar Link pending
expo-ex1040_8.htm Edgar Link pending
expo-ex211_14.htm Edgar Link pending
expo-ex231_10.htm Edgar Link pending
expo-ex311_11.htm Edgar Link pending
expo-ex312_15.htm Edgar Link pending
expo-ex321_7.htm Edgar Link pending
expo-ex322_13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gbidvakgxumz000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending